Clinical Trial Search

Primary: Change in Critical Temperature Thresholds (CTT) From Baseline to Day 70 After Treatment With Omalizumab Compared to Placebo — -10.6; -10.4; -0.3 degree celcius — p=0.001

Primary: Change in Provocation Thresholds From Baseline to Day 70 in Urticaria Factitia Patients After Treatment With Omalizumab Compared to Placebo — -1.8; -2.0; -0.6 wheal…

Primary: Medication Usage — 2.8; 4.6; 2.0; 4.9 number of pills/day

Primary: Cross-Cultural Validity of Thai-version CU-Q2oL — 43.71; 22.11; 9.41; 20.21 Percentage — p=<0.01

Primary: Change From Baseline in the ISS7 at Week 12, TEV-45779 High Dose Compared to XOLAIR High Dose (For European Medicines Agency [EMA] Submission) — -10.92; -10.61 units on…

Primary: Proportion of Patients With Remission of Solar Urticaria Under Experimental Conditions (Phototesting) — 2 Participants

Primary: Change From Baseline in Weekly Itch Severity Score at Week 24 — -6.01; -10.24; -4.81; -7.68 score on a scale — p=0.0005

Primary: Estimated Mean Change From Baseline at Week 4 in 24-hour Systolic Blood Pressure (SBP) Measured by Ambulatory Blood Pressure Monitoring (ABPM) — -1.3 millimeter of…

Primary: Change From Baseline in the Urticaria Activity Score Over 7 Days (UAS7) at Day 57 — -19.16; -24.05; -11.25; -15.69 Score on a Scale — p=0.0559

Primary: Therapeutic Equivalence Based on Change From Baseline in ISS7 at Week 12 in 300 mg Groups — -9.25; -9.96 score on a scale

Primary: Change From Baseline of the Itch Severity Score (ISS7) Score After 12 Weeks of Treatment — -10.11; -9.66; -5.87 Score on a scale — p=<0.001

Primary: Change From Baseline of Weekly Urticaria Activity Score (UAS7) at Week 24 — -20.36; -22.50; -21.26 Score on a scale

Primary: Number of Participants With at Least One Treatment Emergent Adverse Event (AE) — 190 Participants

Primary: Number of Participants Who Were Clinically Well-controlled (UAS7<=6) After the Initial Dosing Period, Relapsed (UAS7>=16) When Treatment Was Discontinued, and Who…

Primary: Reduction in Urticaria Activity Score (UAS7) — 3; 7 Participants